ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Frazier LifeSciences Acquisition Corporation

Frazier LifeSciences Acquisition Corporation (FLAC)

9,87
0,00
(0,00%)
Fermé 31 Janvier 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
9,87
Prix Achat
10,00
Prix Vente
12,75
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
9,87
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

FLAC Dernières nouvelles

NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease

-- Business combination transaction with Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, completed on...

Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.

Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (“FLAC”), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its...

Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors

FLORHAM PARK, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...

NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases

– Leading institutional investors commit approximately $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FLAC - Frequently Asked Questions (FAQ)

What is the current Frazier LifeSciences Acq... share price?
The current share price of Frazier LifeSciences Acq... is US$ 9,87
What is the 1 year trading range for Frazier LifeSciences Acq... share price?
Frazier LifeSciences Acq... has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FOXXFoxx Development Holdings Inc
US$ 6,355
(119,90%)
33,52M
BHILBenson Hill Inc
US$ 3,925
(118,06%)
13,52M
TECXTectonic Therapeutic Inc
US$ 55,18
(114,54%)
5,46M
AMODAlpha Modus Holdings Inc
US$ 3,2299
(109,73%)
125,47M
DOMHDominari Holdings Inc
US$ 3,61
(59,03%)
4,24M
CLEUChina Liberal Education Holdings Ltd
US$ 0,149
(-98,08%)
312,2M
CRGXCARGO Therapeutics Inc
US$ 3,39
(-74,30%)
21,39M
TDTHTrident Digital Tech Holdings Ltd
US$ 1,0159
(-58,87%)
2,46M
EVTVEnvirotech Vehicles Inc
US$ 0,338202
(-49,30%)
4,79M
IRWDIronwood Pharmaceuticals Inc
US$ 2,29
(-38,44%)
10,55M
NVDANVIDIA Corporation
US$ 124,65
(0,77%)
394,43M
CLEUChina Liberal Education Holdings Ltd
US$ 0,149
(-98,08%)
312,2M
MGOLMGO Global Inc
US$ 0,1199
(17,90%)
167,92M
SPGCSacks Parente Golf Inc
US$ 0,93
(57,63%)
129,47M
AMODAlpha Modus Holdings Inc
US$ 3,2299
(109,73%)
126,59M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées